The best indicator for Humana (HUM)
We backtested 20 indicators across daily, weekly and hourly charts on real Humana (HUM) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
Stochastic
On the daily chart, this is the strongest risk-adjusted edge we found for Humana (HUM) over ~44.4 years — trailing buy-and-hold by 0.4% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | Stochastic ✓ | Daily | 12.0% | 0.58 | -69.6% | 74.4% | 238 | -0.4% |
| 2 | WaveTrend (8/6/4) ✓ | Daily | 9.3% | 0.46 | -71.3% | 72.1% | 172 | -3.2% |
| 3 | Williams %R ✓ | Daily | 8.1% | 0.43 | -74.4% | 69.9% | 296 | -4.4% |
| 4 | Money Flow Index ✓ | Daily | 7.8% | 0.43 | -69.7% | 73.5% | 49 | -4.7% |
| 5 | Donchian Breakout ✓ | Weekly | 7.4% | 0.42 | -61.1% | 48.5% | 33 | -5.0% |
| 6 | CCI ✓ | Daily | 6.6% | 0.38 | -72.5% | 70.5% | 220 | -5.9% |
| 7 | Bollinger Breakout ✓ | Weekly | 5.2% | 0.36 | -55.8% | 55.8% | 43 | -7.2% |
| 8 | RSI Trend (>50) ✓ | Weekly | 5.7% | 0.35 | -80.3% | 46.1% | 128 | -6.7% |
| 9 | SMA 50/200 Cross ✓ | Daily | 5.3% | 0.32 | -74.3% | 39.4% | 33 | -7.2% |
| 10 | Donchian Midline ✓ | Weekly | 4.9% | 0.32 | -76.6% | 46.6% | 131 | -7.5% |
| 11 | EMA 50/200 Cross ✓ | Daily | 4.7% | 0.31 | -77.0% | 37.5% | 32 | -7.7% |
| 12 | RSI Mean-Reversion ✓ | Daily | 4.1% | 0.31 | -76.6% | 76.5% | 68 | -8.3% |
| 13 | EMA-10 Trend ✓ | Daily | 4.8% | 0.31 | -81.9% | 41.7% | 1020 | -7.7% |
| 14 | EMA 20/50 Cross ✓ | Weekly | 4.8% | 0.31 | -83.2% | 44.4% | 18 | -7.6% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Humana (HUM), Stochastic on the daily timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.